Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication
Helicobacter, 09/14/09
Zou J et al. – The authors review suggests that supplementation with Lactobacilli could be effective in increasing eradication rates of anti–H. pylori therapy for first–treated patients. Furthermore, Lactobacilli showed a positive impact on some H. pylori therapy–related side effects.
Related Articles
Peptic ulcer disease and helicobacter pylori infection at kano, nigeria
The Internet Journal of Gastroenterology, 11/11/09
Relevance Score: 69%
Reactive Nitrogen Species Mediate DNA Damage in Helicobacter pylori-Infected Gastric Mucosa
Helicobacter, 11/09/09
Relevance Score: 68%
Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country
Acta Pediatrica, 10/28/09
Relevance Score: 68%
In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability
Journal of Pharmacy and Pharmacology, 10/14/09
Relevance Score: 68%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 68%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/17/09
Mechanical bowel preparation does not affect the intramucosal bacterial colony count
International Journal of Colorectal Disease, 12/17/09
The effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study
Alimentary Pharmacology and Therapeutics, 12/17/09
Article Search
Sponsor


See Latest Articles


